. Author manuscript; available in PMC: 2022 Oct 27.

Published in final edited form as: Int J Radiat Oncol Biol Phys. 2021 Feb 1;110(4):1082–1089. doi: 10.1016/j.ijrobp.2021.01.043

Table 2:

Toxicity Details and Differences between Treatment Cohorts

	IMRT (N=1282)	PBT (N=568)	Total (N=1850)	P Value

Late GU Toxicity (any grade)
Frequency	267 (20.8%)	200 (35.2%)	467 (25.2%)	<0.001
Urgency	256 (20.0%)	187 (32.9%)	443 (23.9%)	<0.001
Obstruction	264 (20.6%)	103 (18.1%)	367 (19.8%)	0.221
Dysuria	252 (19.7%)	141 (24.8%)	393 (21.2%)	0.012
Stenosis	212 (16.5%)	87 (15.3%)	299 (16.2%)	0.511
Urinary Incontinence	258 (20.1%)	126 (22.2%)	384 (20.8%)	0.314
Cystitis	249 (19.4%)	97 (17.1%)	346 (18.7%)	0.233

Late GI Toxicity (any grade)
Diarrhea	253 (19.7%)	104 (18.3%)	357 (19.3%)	0.474
Proctitis	265 (20.7%)	132 (23.2%)	397 (21.5%)	0.214
Rectal Bleeding	295 (23.0%)	177 (31.2%)	472 (25.5%)	<0.001
Bowel Incontinence	247 (19.3%)	96 (16.9%)	343 (18.5%)	0.227